Masi G - Search Results

1

Tumour mutational burden, microsatellite instability, and actionable alterations in metastatic colorectal cancer: Next-generation sequencing results of TRIBE2 study.

Antoniotti C, Korn WM, Marmorino F, Rossini D, Lonardi S, Masi G, Randon G, Conca V, Boccaccino A, Tomasello G, Passardi A, Swensen J, Ugolini C, Oberley M, Tamburini E, Casagrande M, Domenyuk V, Fontanini G, Giordano M, Abraham J, Spetzler D, Falcone A, Lenz HJ, Cremolini C. Antoniotti C, et al. Among authors: masi g. Eur J Cancer. 2021 Sep;155:73-84. doi: 10.1016/j.ejca.2021.06.037. Epub 2021 Aug 5. Eur J Cancer. 2021. PMID: 34365081

2

Suramin in combination with weekly epirubicin for patients with advanced hormone-refractory prostate carcinoma.

Falcone A, Antonuzzo A, Danesi R, Allegrini G, Monica L, Pfanner E, Masi G, Ricci S, Del Tacca M, Conte P. Falcone A, et al. Among authors: masi g. Cancer. 1999 Aug 1;86(3):470-6. doi: 10.1002/(sici)1097-0142(19990801)86:3<470::aid-cncr15>3.0.co;2-7. Cancer. 1999. PMID: 10430255 Clinical Trial.

3

Relationship between 5-fluorouracil disposition, toxicity and dihydropyrimidine dehydrogenase activity in cancer patients.

Di Paolo A, Danesi R, Falcone A, Cionini L, Vannozzi F, Masi G, Allegrini G, Mini E, Bocci G, Conte PF, Del Tacca M. Di Paolo A, et al. Among authors: masi g. Ann Oncol. 2001 Sep;12(9):1301-6. doi: 10.1023/a:1012294617392. Ann Oncol. 2001. PMID: 11697844 Free article. Clinical Trial.

4

A phase I and pharmacokinetic study of irinotecan given as a 7-day continuous infusion in metastatic colorectal cancer patients pretreated with 5-fluorouracil or raltitrexed.

Masi G, Falcone A, Di Paolo A, Allegrini G, Danesi R, Barbara C, Cupini S, Del Tacca M. Masi G, et al. Clin Cancer Res. 2004 Mar 1;10(5):1657-63. doi: 10.1158/1078-0432.ccr-1585-3. Clin Cancer Res. 2004. PMID: 15014016 Clinical Trial.

5

First-line treatment of metastatic colorectal cancer with irinotecan, oxaliplatin and 5-fluorouracil/leucovorin (FOLFOXIRI): results of a phase II study with a simplified biweekly schedule.

Masi G, Allegrini G, Cupini S, Marcucci L, Cerri E, Brunetti I, Fontana E, Ricci S, Andreuccetti M, Falcone A. Masi G, et al. Ann Oncol. 2004 Dec;15(12):1766-72. doi: 10.1093/annonc/mdh470. Ann Oncol. 2004. PMID: 15550581 Free article. Clinical Trial.

6

EGF-receptor targeting with monoclonal antibodies in colorectal carcinomas: rationale for a pharmacogenomic approach.

Loupakis F, Vasile E, Santini D, Masi G, Falcone A, Graziano F. Loupakis F, et al. Among authors: masi g. Pharmacogenomics. 2008 Jan;9(1):55-69. doi: 10.2217/14622416.9.1.55. Pharmacogenomics. 2008. PMID: 18154448 Review.

7

Triplet combination of fluoropyrimidines, oxaliplatin, and irinotecan in the first-line treatment of metastatic colorectal cancer.

Masi G, Vasile E, Loupakis F, Bursi S, Ricci S, Petrini I, Fontana A, Allegrini G, Falcone A. Masi G, et al. Clin Colorectal Cancer. 2008 Jan;7(1):7-14. doi: 10.3816/CCC.2008.n.002. Clin Colorectal Cancer. 2008. PMID: 18279572 Review.

8

A pharmacokinetic and pharmacodynamic study on metronomic irinotecan in metastatic colorectal cancer patients.

Allegrini G, Falcone A, Fioravanti A, Barletta MT, Orlandi P, Loupakis F, Cerri E, Masi G, Di Paolo A, Kerbel RS, Danesi R, Del Tacca M, Bocci G. Allegrini G, et al. Among authors: masi g. Br J Cancer. 2008 Apr 22;98(8):1312-9. doi: 10.1038/sj.bjc.6604311. Epub 2008 Mar 25. Br J Cancer. 2008. PMID: 18362940 Free PMC article.

9

First-line chemotherapy in metastatic colorectal cancer: new approaches and therapeutic algorithms. Always hit hard first?

Loupakis F, Masi G, Vasile E, Falcone A. Loupakis F, et al. Among authors: masi g. Curr Opin Oncol. 2008 Jul;20(4):459-65. doi: 10.1097/CCO.0b013e32830218ea. Curr Opin Oncol. 2008. PMID: 18525344 Review.

10

Liver-only metastatic colorectal cancer patients and thymidylate synthase polymorphisms for predicting response to 5-fluorouracil-based chemotherapy.

Graziano F, Ruzzo A, Loupakis F, Santini D, Catalano V, Canestrari E, Maltese P, Bisonni R, Fornaro L, Baldi G, Masi G, Falcone A, Tonini G, Giordani P, Alessandroni P, Giustini L, Vincenzi B, Magnani M. Graziano F, et al. Among authors: masi g. Br J Cancer. 2008 Sep 2;99(5):716-21. doi: 10.1038/sj.bjc.6604555. Epub 2008 Aug 12. Br J Cancer. 2008. PMID: 18728661 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

672 results

Search Page

Filters